SCHEMBL927537

SCHEMBL927537

CC(C)(C)Oc1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCCOc2ccc(CC(=O)O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 7/20 0.44
MMP3 P08254 5/20 0.44
ALDH1A1 P00352 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
MAPT P10636 1/20 0.39
PTGER3 P43115 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CACNA1B Q00975 1/20 0.38
MMP1 P03956 2/20 0.38
MMP7 P09237 2/20 0.38
MMP13 P45452 2/20 0.38
MMP2 P08253 1/20 0.38
PPARD Q03181 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926278 0.92 MMP8 (0.44) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4844597 0.89 MMP8 (0.44) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4841566 0.87 MMP8 (0.45) MMP8MMP3ALDH1A1NPSR1KMT2A
SCHEMBL4833189 0.87 MMP8 (0.49) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL926348 0.87 MMP8 (0.49) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4842792 0.87 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4840055 0.86 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4840169 0.86 FFAR4 (0.46) MMP8MMP3ALDH1A1NPSR1CACNA1B
SCHEMBL926649 0.85 MMP8 (0.44) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4841439 0.85 PPARD (0.46) MMP8MMP3ALDH1A1NPSR1PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD MMP8 4719/4885MMP3 4694/4885ALDH1A1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.